Navigation Links
BioMed Realty Trust Reports Fourth Quarter and Full-Year 2009 Financial Results
Date:2/10/2010
span> per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from October 16, 2009 through January 15, 2010. The fourth quarter common share dividend represented a 27.3% increase over the third quarter 2009 dividend. For the full year 2009, the company declared dividends totaling $0.695 per common share and $1.84376 per Series A preferred share.
Earnings Guidance
Based on the strong results for the fourth quarter and the dilutive impact of the exchangeable notes offering in January 2010, the company has revised its initial 2010 guidance for net income per diluted share and FFO per diluted share. The company's revised guidance is set forth and reconciled below.
2010
(Low - High)
Projected net income per diluted share
available to common stockholders $0.21 – $0.31
Add:
Noncontrolling interests in operating
partnership $0.01
Real estate depreciation and amortization $1.01
Projected FFO per diluted share $1.23 – $1.33
Consistent with the initial 2010 guidance, the company's revised 2010 guidance does not include the impact of potential future financing and investment activities.
The foregoing estimates are forward-looking and reflect management's view of current and future market conditions, including certain assumptions with respect to leasing activity, rental rates, occupancy levels, financing transactions, interest rates, and the amount and timing of development and redevelopment activities. The c
'/>"/>
| SOURCE BioMed Realty Trust, Inc. Copyright©2010 PR Newswire. All rights reserved |
Related medicine news :
1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends
Post Your Comments:
(Date:5/23/2013)... of borderline personality disorder often mimic traits of ... researchers in Canada say they have identified a ... disorder: a tendency to misinterpret emotions expressed by ... facial emotions and will see a negative emotion ... clinical neuropsychologist and assistant professor at the University ...
(Date:5/23/2013)... (HealthDay News) -- A shortage of a critical tuberculosis ... the United States to contain the spread of the ... drug, isoniazid (INH), was first used in 1951 and ... core of any first-line treatment for tuberculosis (TB). Patients ... according to the U.S. Centers for Disease Control and ...
(Date:5/23/2013)... at Emory Vaccine Center have shown that an immune ... responses in mice against viral infections. , The results ... , "Our findings highlight how IL-21 could be important ... Ata Ur Rasheed Mohammed, PhD, the first author of ... director of the Emory Vaccine Center and a Georgia ...
(Date:5/23/2013)... Netsmart today announced it is ... healthcare information technology (HIT) providers for 2013. , The HCI ... Healthcare Informatics magazine. Netsmart’s ranking of #49 is ... continued growth is largely due to our commitment to helping ... healthcare where resources are scarce, the demand for care is ...
(Date:5/23/2013)... examining outcomes for advanced heart-failure patients over the ... the increased availability and use of new therapies, ... caused by the rapid onset of severe abnormal ... the team found that even today, with these ... than three years after being diagnosed with advanced ...
Breaking Medicine News(10 mins):Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2Health News:Netsmart Named to Healthcare Informatics Top 100 List 2Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 2Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 3[0] People With Borderline Personality Disorder May Misinterpret Facial Emotions[0] Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report[0] Vaccine blackjack: IL-21 critical to fight against viral infections[0] Netsmart Named to Healthcare Informatics Top 100 List[0] Death rates decline for advanced heart failure patients, but outcomes are still not ideal
... how cocaine corrupts the brain and becomes addictive. These findingsthe ... cocaine rewardwere published in Science on October 15. ... treating those addicted to the drug. Led by ... Neuroscience at Mount Sinai School of Medicine and first author ...
... The US Department of Defense (DOD) has awarded a ... Research and the University of Cincinnati to further develop ... severe brain injury. Management of severe brain trauma ... critical first few hours and days after an injury. ...
... , MONDAY, Oct. 18 (HealthDay News) -- Canadian ... the so-called swine flu -- to be very severe this ... of 50, especially those with chronic health conditions, get immunized ... results of blood tests given to 1,127 people in the ...
... Institute has awarded a $4.37 million grant to Jeffrey ... to advance a recent scientific laboratory discovery into a ... under the American Recovery and Reinvestment Act, will help ... by Toretsky and his team a critical step ...
... Texas (October 18, 2010) The latest colorectal ... Gastroenterology,s (ACG) 75th Annual Scientific meeting in San ... evidence that suggests significant disparity in colorectal cancer ... the first in a series of studies investigating ...
... Antonio, Texas (October 18, 2010) Investment in screening ... 50 and 64, is needed to reduce the costs ... the results of a new study, "Cost-Savings to Medicare ... unveiled today at the American College of Gastroenterology,s (ACG) ...
Cached Medicine News:Health News:Mount Sinai researchers discover why cocaine is so addictive 2Health News:Feinstein Institute to share $5M US Department of Defense grant 2Health News:H1N1 Unlikely to Cause Flu Pandemic in 2010-11: Analysis 2Health News:$4.37 million NCI grant accelerates recent laboratory finding in Ewing's sarcoma 2Health News:$4.37 million NCI grant accelerates recent laboratory finding in Ewing's sarcoma 3Health News:Notable racial disparities in diagnosis, treatment and outcomes of colorectal cancer 2Health News:Notable racial disparities in diagnosis, treatment and outcomes of colorectal cancer 3Health News:Investment in CRC screening targeting pre-medicare population could cut medicare treatment costs 2Mount Sinai researchers discover why cocaine is so addictiveFeinstein Institute to share $5M US Department of Defense grantH1N1 Unlikely to Cause Flu Pandemic in 2010-11: Analysis$4.37 million NCI grant accelerates recent laboratory finding in Ewing's sarcomaNotable racial disparities in diagnosis, treatment and outcomes of colorectal cancerInvestment in CRC screening targeting pre-medicare population could cut medicare treatment costs
(Date:5/23/2013)... , May 23, 2013 Every day, their baby ... air to his lungs. April and Bryan Gionfriddo ... predictions weren,t true. "Quite a few doctors said ... alive," says April Gionfriddo , about her ... Anything that would work, we would take it and run ...
(Date:5/23/2013)... , May 23, 2013 Direct to ... mastectomy is an appropriate option for many women ... surgically reduce their breast cancer risk, or with ... expansion process and a second surgery to insert ... the same surgery as mastectomy can be a ...
(Date:5/23/2013)... TEL AVIV, Israel , May 23, 2013 ... of BrainTech Israel 2013 , Israel,s ... take place on October 14 th -15 th in ... 2 nd most innovative city in the world by ... the "Start-up Nation." BrainTech Israel 2013 will showcase ...
Breaking Medicine Technology:Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3[0] Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing[0] Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results[0] Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference
... DIEGO, Sept. 20, 2011 Orexigen® Therapeutics, Inc. (Nasdaq: ... recent meeting with senior officials in FDA,s Office of ... OND,s design requirements for a cardiovascular outcomes trial (CVOT) ... (CRL) received in January 2011. Orexigen believes that these ...
... 2011 Innovadex and New Hope Natural Media, ... facilitate the electronic exchange of documents and lead capture at ... food, beverage, dietary supplements and nutricosmetics sectors. Engredea will be ... The Innovadex product search platform, its Sales App and iPad ...
Cached Medicine Technology:Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 2Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 3Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 4Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 5Engredea Alliance With Innovadex Brings iPad Technology and Smarter, Greener Customer Connections to the Trade Show Floor 2Engredea Alliance With Innovadex Brings iPad Technology and Smarter, Greener Customer Connections to the Trade Show Floor 3Engredea Alliance With Innovadex Brings iPad Technology and Smarter, Greener Customer Connections to the Trade Show Floor 4... The BD Macro-Vue RPR (Rapid ... and Tear-drop Tests are nontreponemal testing ... syphilis described in A Manual of ... in this manual are the most ...
Rapid Plasma Reagin (RPR) set is a non-treponemal flocculation test that is,used for the qualitative and semi-quantitative determination of reagin,antibodies in serum or plasma from persons with syph...
For use as a quality assurance reagent in assays detecting IgG antibody to mumps virus (mumps IgG), IgG antibody to measles (Rubeola) virus (measles IgG) and IgG antibody to varicella zoster virus (V...
... For use as a ... detecting IgG antibody to Toxoplasma ... to rubella virus (rubella IgG), ... IgG) and IgG antibody to ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |